Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
September 6, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for June 4, 2003 Subscribe to this News Feed      
 

Saving Your Babys Cord Blood At Birth- a true once in a lifetime opportunity

Baby Chord Lifesciences enables parents to collect and store their babys cord blood stem cells at birth. Saving the babys cord blood stem cells at birth eliminates the donor problem, and the odds associated with transplantation because the child is receiving his or her own blood.

Mississauga, Ontario (PRWEB) June 5th, 2003 – Biogene Life Sciences Inc. announces the launch of Baby Chord Lifesciences its cord blood stem cell division. Using key genetic and cryogenic competencies of its parent company, Baby Chord Lifesciences enables parents to collect and store their babys cord blood stem cells at birth. Preserving the babys cord blood stem cells at birth eliminates the donor problem, and the odds associated with transplantation because the child is receiving his or her own blood.

As parents, our choices can and often does affect our future and our familys; collecting and saving our babys umbilical cord blood is a true once in a lifetime opportunity; and may be the most important decision a parent can make for their childs future health" explains Evelyn Soliven-Llaguno Baby Chords Vice President. Medical science has discovered that cord blood is rich in stem cells which are the building blocks of our blood and immune system. Stem cells form the white cells that fight infection, the red cells that carry oxygen and the platelets that promote clotting. Stem cells can and are being used to treat a variety of life-threatening diseases. Not only used to combat leukemia, blood disorders like sickle cell anemia and certain cancers but new stem cell developments are opening- up numerous , and exciting possibilities in the future which include gene therapies. It is ironic, that for centuries some Asian cultures were ridiculed because they believed in saving a babys umbilical cord. Now medical sciences has proven their beliefs has some merit because the normally discarded umbilical cord blood now has the promise of providing and being a gift of life"

To learn more about Baby Chord LifeSciences and its parent company Biogene Life Sciences Inc, please visit the websites at www.babychord.com and www.biogene.ca or contact us throughout Canada & USA at 1 800 665 4526. Baby Chord is now accepting enrollment into its cord blood banking services.

(Biogene Life Sciences Inc., Baby Chord Lifesciences and its biotech partners/affiliates have no involvement in anyway with human cloning, and does not support the process)

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Brad Soliven
Biogene Life Sciences
1 800 665 4526
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright